Albany Molecular Research Inc (NASDAQ:AMRI)

19.08
Delayed Data
As of Apr 24
 +0.04 / +0.21%
Today’s Change
13.73
Today|||52-Week Range
23.95
+17.20%
Year-to-Date
No recent news for Albany Molecular Research Inc.

Today’s Trading

Previous close19.04
Today’s open19.10
Day’s range18.94 - 19.37
Volume314,510
Average volume (3 months)427,051
Market cap$624.8M
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)-125.00%
Earnings growth (this year)+30.28%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)+12.17%
P/E ratioNM
Price/Sales1.86
Price/Book2.57

Competitors

 Today’s
change
Today’s
% change
EXELExelixis Inc-0.02-0.65%
LXRXLexicon Pharmaceutic...+0.03+2.80%
AMRNAmarin Corporation P...-0.10-4.12%
ARWRArrowhead Research C...+0.05+0.69%
Data as of 4:14pm ET, 04/24/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)$0.15
Annual revenue (last year)$276.6M
Annual profit (last year)-$3.3M
Net profit margin-1.19%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Financial Officer, Treasurer &
Senior VP
Felicia Ladin
Corporate headquarters
Albany, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers